Get started
CCC

CANTABIO PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

CTBO chart


Full chart

Key stats


Market capitalization
‪22.77 K‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪17.86 K‬
Beta (1Y)
—

About CANTABIO PHARMACEUTICALS INC


Sector
Health Technology
Industry
Biotechnology
CEO
Gergely Tóth
Website
cantabio.com
Headquarters
Palo Alto
Founded
2009
FIGI
BBG00329G3X1
Cantabio Pharmaceuticals, Inc. is a preclinical stage biotechnology company, which engages in the commercialization of novel therapies and the intellectual property generated from the research and development activities for Parkinson's, Alzheimer's diseases, and any other related diseases. It focuses on identification and development of small molecule pharmacological chaperones targeting proteins that misfold and aggregated in vivo vivo levels of proteins which display loss of function during disease conditions. The company was founded by Gergely Toth on February 6, 2012 and is headquartered in Palo Alto, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CTBO is 1.01 USD — it has decreased by −95.96% in the past 24 hours. Watch CANTABIO PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CANTABIO PHARMACEUTICALS INC stocks are traded under the ticker CTBO.
CTBO reached its all-time high on Jun 7, 2016 with the price of 18,950.00 USD, and its all-time low was 1.01 USD and was reached on Aug 19, 2021. View more price dynamics on CTBO chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track CANTABIO PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
No, CTBO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CTBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANTABIO PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CANTABIO PHARMACEUTICALS INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CANTABIO PHARMACEUTICALS INC stock shows the sell signal. See more of CANTABIO PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.